Normalization of metastatic burden by tumor weight to account for differences in tumor weight in vivo still resulted in significant differences between control and knockdown cells (Fig 3B), consistent with Pvrl1 being a tumor progression gene. This evidence concerns the gene NECTIN1 and neoplasm.